Key result
Transcatheter aortic valve implantation remains inappropriate for widespread use in low-risk, young patients due to unresolved issues with durability, long-term follow-up, and complications.
Cautions against the widespread use of transcatheter aortic valve implantation in young, low-risk patients due to unresolved issues with durability and complications.
The PARTNER 3 and Evolut LRT trials have provided the evidence base for transcatheter aortic valve implantation in low-risk patients. However, there are still issues with durability, long-term follow up and complications before their widespread use can be considered appropriate in this group.
No takes yet. Share an insight, caveat, or question.
Luthra et al. (2021) studied this question. Transcatheter aortic valve implantation remains inappropriate for widespread use in low-risk, young patients due to unresolved issues with durability, long-term follow-up, and complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: